tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Income Statement

Compare
2 Followers

Alembic Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), Alembic Pharmaceuticals Limited's total revenue was ₹17.11B, an increase of 9.54% from the same quarter last year. In Q1, Alembic Pharmaceuticals Limited's net income was ₹1.54B. See Alembic Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B₹ 53.93B
Gross Profit
₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B₹ 40.53B
Operating Expenses
₹ 20.90B₹ 19.24B₹ 18.97B₹ 19.77B₹ 17.21B
Depreciation and Amortization
₹ 2.59B₹ 2.53B₹ 2.58B₹ 2.71B₹ 1.69B
EBITDA
₹ 9.89B₹ 9.14B₹ 6.96B₹ 8.59B₹ 14.66B
Operating Income
₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B₹ 23.32B
Other Income/Expenses
₹ -19.95B₹ -18.77B₹ -16.26B₹ -12.05B₹ -9.32B
Pretax Income
₹ 7.07B₹ 6.32B₹ 3.55B₹ 6.25B₹ 14.00B
Net Income
₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B₹ 11.46B
Per Share Metrics
Basic EPS
₹ 29.68₹ 31.33₹ 17.40₹ 26.50₹ 59.18
Diluted EPS
₹ 29.68₹ 31.33₹ 17.40₹ 26.50₹ 59.18
Weighted Average Shares Outstanding
196.56M 196.56M 196.56M 196.56M 193.74M
Weighted Average Shares Outstanding (Diluted)
196.56M 196.56M 196.56M 196.56M 193.74M
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History